Wafik S. El-Deiry: Dr. Vinay Jain organizes global Oncologic Specialty summits on accelerating clinical trials

Wafik S. El-Deiry shared on LinkedIn:

“Great to see Dr. Vinay Jain this morning. Dr. Jain, the CEO of DAVA Oncology is an experienced oncologist who previously founded PER, and other non-profits. He organizes amazing global Oncologic Specialty summits focused on accelerating clinical trials driven by leaders in the field. The mix of academia and industry makes these meetings very special and extremely good and focused learning opportunities.”

Source: Wafik S. El-Deiry/LinkedIn

Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.

Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development. .